Deficits in cortical basket cell signaling in schizophrenia
精神分裂症皮质篮细胞信号传导缺陷
基本信息
- 批准号:8050160
- 负责人:
- 金额:$ 4.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-12-01 至 2011-11-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAmericanAutopsyAxonCalcium-Binding ProteinsClinicalCognitionCognitiveConfocal MicroscopyDataDelusionsDevelopmentDiseaseDrug Delivery SystemsEmploymentEnzymesFamilyFrequenciesGABA ReceptorGlutamate DecarboxylaseGoalsHallucinationsHumanImage AnalysisImpaired cognitionImpairmentIn Situ HybridizationIndividualInterneuronsKnowledgeLabelLearningMediatingMembraneMessenger RNAMethodsMicroscopicMonkeysMyoepithelial cellNatureNeuronsParvalbuminsPatientsPerceptionPerformancePharmacotherapyPopulationPrefrontal CortexPresynaptic TerminalsProcessProtein SubunitsProteinsPyramidal CellsRelapseRelative (related person)ResearchSchizophreniaSchoolsShort-Term MemorySignal TransductionSocial FunctioningSocietiesSynapsesTestingTissuesbasecostdensitygamma-Aminobutyric Acidhippocampal pyramidal neuronimprovedmRNA Expressionneural circuitneuronal cell bodynovelpostsynapticpresynapticreceptorrelating to nervous systemresearch studysocial cognitionsocial integrationtherapeutic targettool
项目摘要
DESCRIPTION (provided by applicant): Schizophrenia is a debilitating disorder which affects 1% of the population at a substantial cost to the individual, their family and society. Cognitive ability is the best predictor of employment, social integration and relapse in schizophrenia, but current pharmacotherapies do not address cognitive dysfunction. A core component of cognition is working memory (WM), which depends upon proper activation of dorsolateral prefrontal cortex (DLPFC) circuitry, and both WM and DLPFC activation are impaired in schizophrenia. To identify therapeutic targets for improving WM, the underlying nature of DLPFC circuitry abnormalities must be identified. Parvalbumin (PV) basket cells synapse onto the perisomatic region of pyramidal cells and are critical for synchronizing neural populations to oscillate in the gamma range (30-90 Hz). Gamma oscillations are thought to underlie WM ability, and schizophrenia patient show impaired gamma oscillations during WM tasks. Recent evidence demonstrates that PV basket cell axonal arbors and synapses are significantly diminished if adequate levels of GAD67 are not available during development In schizophrenia DLPFC, GAD67 mRNA is undetectable in 45% of PV interneurons, suggesting these GAD67-negative, PV-positive interneurons form fewer connections with pyramidal cells. Thus, alterations in PV basket cell connections may contribute to the circuitry abnormalities underlying impaired WM in schizophrenia. To test the hypothesis that PV basket cell inputs are diminished in schizophrenia, pre- and postsynaptic markers are examined in DLPFC tissue from schizophrenia relative to comparison subjects. In Aim 1, a novel confocal microscopic method is used to test the hypothesis that DLPFC pyramidal somata receives fewer PV basket cell inputs in schizophrenia. PV basket cells synapsing onto pyramidal somata signal via GABAa receptors containing alpha subunits. Thus, in Aim 2, the same method is used to test the hypothesis that the number of alpha subunit clusters on pyramidal somal membranes is lower in schizophrenia. Recent evidence indicates that PV basket cell inputs onto pyramidal cells, but not interneurons, are important for gamma ocsillations. Thus, in Aim 3 the hypothesis that alpha subunits are exclusively lower in pyramidal cells is tested using dual-label in situ hybridization to determine the percentage of pyramidal cells and interneuons containing alpha mRNA in schizophrenia. Relevance: Schizophrenia affects over 3 million Americans at a cost of $62 billion a year, and cognitive ability is the best predictor of employment and relpase in these patients. No treatments which improve cognition in schizophrenia are currently available. The proposed project examines circuitry abnormalities which likely contribute to cognitive impairment in schizophrenia.
描述(由申请人提供):精神分裂症是一种使人衰弱的疾病,对人口,其家庭和社会的巨额成本影响1%的人口。认知能力是精神分裂症中就业,社会融合和复发的最佳预测指标,但是当前的药物疗法无法解决认知功能障碍。认知的核心组成部分是工作记忆(WM),取决于背外侧前额叶皮层(DLPFC)电路的适当激活,而在精神分裂症中,WM和DLPFC激活都受损。为了确定改善WM的治疗靶标,必须确定DLPFC电路异常的潜在性质。白蛋白(PV)篮细胞突触到锥体细胞的围核区域,对于同步神经种群至关重要,以振荡在伽马范围内(30-90 Hz)。人们认为伽马振荡是WM能力的基础,精神分裂症患者在WM任务期间表现出γ振荡受损。最近的证据表明,如果在精神分裂症DLPFC的开发过程中无法获得足够水平的GAD67,则PV篮细胞轴突轴承和突触会显着减少,GAD67 mRNA在45%的PV Interneurons中无法检测到GAD67-NECH67-NECH67-NECHATIAL,PV型,PV-POSSIDINE NENERONS与PV-PV-PosIteNERONS connections connections connections connections connections connections connections。因此,PV篮细胞连接的改变可能会导致精神分裂症中WM损害的电路异常。为了测试精神分裂症中PV篮细胞输入减少的假设,相对于比较受试者,在精神分裂症的DLPFC组织中检查了前后突触后标记。在AIM 1中,一种新型的共聚焦显微镜方法用于检验以下假设:DLPFC锥体somata在精神分裂症中获得的PV篮细胞输入较少。 PV篮细胞通过包含α亚基的GABAA受体突触到锥体somata信号。因此,在AIM 2中,使用相同的方法来检验以下假设:在精神分裂症中,锥体som膜上α亚基簇的数量较低。最近的证据表明,PV篮细胞在锥体细胞上输入(而不是中间神经元)对于γ刻度很重要。因此,在AIM 3中,使用双标记的原位杂交测试了锥体细胞中α亚基仅较低的假设,以确定精神分裂症中含有αmRNA的锥体细胞和含有alpha mRNA的中间的百分比。相关性:精神分裂症每年影响超过300万美国人,成本为620亿美元,而认知能力是这些患者就业和利用酶的最佳预测指标。目前尚无改善精神分裂症认知的治疗方法。拟议的项目研究了电路异常,这可能导致精神分裂症的认知障碍。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JILL RENEE' Glausier其他文献
JILL RENEE' Glausier的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JILL RENEE' Glausier', 18)}}的其他基金
Neural substrates of elevated striatal dopamine synthesis and release in schizophrenia
精神分裂症纹状体多巴胺合成和释放升高的神经基质
- 批准号:
10409842 - 财政年份:2021
- 资助金额:
$ 4.84万 - 项目类别:
Neural substrates of elevated striatal dopamine synthesis and release in schizophrenia
精神分裂症纹状体多巴胺合成和释放升高的神经基质
- 批准号:
10300776 - 财政年份:2021
- 资助金额:
$ 4.84万 - 项目类别:
Excitatory signaling and oxidative phosphorylation alterations in schizophrenia
精神分裂症的兴奋性信号传导和氧化磷酸化改变
- 批准号:
9248449 - 财政年份:2016
- 资助金额:
$ 4.84万 - 项目类别:
Excitatory signaling and oxidative phosphorylation alterations in schizophrenia
精神分裂症的兴奋性信号传导和氧化磷酸化改变
- 批准号:
9413230 - 财政年份:2016
- 资助金额:
$ 4.84万 - 项目类别:
Excitatory signaling and oxidative phosphorylation alterations in schizophrenia
精神分裂症的兴奋性信号传导和氧化磷酸化改变
- 批准号:
9108013 - 财政年份:2016
- 资助金额:
$ 4.84万 - 项目类别:
Deficits in cortical basket cell signaling in schizophrenia
精神分裂症皮质篮细胞信号传导缺陷
- 批准号:
7807659 - 财政年份:2009
- 资助金额:
$ 4.84万 - 项目类别:
D1 AND D5 RECEPTOR SIGNALING IN MONKEY PFC
猴 PFC 中的 D1 和 D5 受体信号传导
- 批准号:
7958178 - 财政年份:2009
- 资助金额:
$ 4.84万 - 项目类别:
D1 AND D5 RECEPTOR SIGNALING IN MONKEY PFC
猴 PFC 中的 D1 和 D5 受体信号传导
- 批准号:
7715760 - 财政年份:2008
- 资助金额:
$ 4.84万 - 项目类别:
D1 AND D5 RECEPTOR SIGNALING IN MONKEY PFC
猴 PFC 中的 D1 和 D5 受体信号传导
- 批准号:
7562619 - 财政年份:2007
- 资助金额:
$ 4.84万 - 项目类别:
D1 AND D5 RECEPTOR SIGNALING IN MONKEY PFC
猴 PFC 中的 D1 和 D5 受体信号传导
- 批准号:
7349285 - 财政年份:2006
- 资助金额:
$ 4.84万 - 项目类别:
相似国自然基金
海洋缺氧对持久性有机污染物入海后降解行为的影响
- 批准号:42377396
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
氮磷的可获得性对拟柱孢藻水华毒性的影响和调控机制
- 批准号:32371616
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
还原条件下铜基催化剂表面供-受电子作用表征及其对CO2电催化反应的影响
- 批准号:22379027
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CCT2分泌与内吞的机制及其对毒性蛋白聚集体传递的影响
- 批准号:32300624
- 批准年份:2023
- 资助金额:10 万元
- 项目类别:青年科学基金项目
在轨扰动影响下空间燃料电池系统的流动沸腾传质机理与抗扰控制研究
- 批准号:52377215
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Executive functions in urban Hispanic/Latino youth: exposure to mixture of arsenic and pesticides during childhood
城市西班牙裔/拉丁裔青年的执行功能:童年时期接触砷和农药的混合物
- 批准号:
10751106 - 财政年份:2024
- 资助金额:
$ 4.84万 - 项目类别:
Fluency from Flesh to Filament: Collation, Representation, and Analysis of Multi-Scale Neuroimaging data to Characterize and Diagnose Alzheimer's Disease
从肉体到细丝的流畅性:多尺度神经影像数据的整理、表示和分析,以表征和诊断阿尔茨海默病
- 批准号:
10462257 - 财政年份:2023
- 资助金额:
$ 4.84万 - 项目类别:
Novel application of pharmaceutical AMD3100 to reduce risk in opioid use disorder: investigations of a causal relationship between CXCR4 expression and addiction vulnerability
药物 AMD3100 降低阿片类药物使用障碍风险的新应用:CXCR4 表达与成瘾脆弱性之间因果关系的研究
- 批准号:
10678062 - 财政年份:2023
- 资助金额:
$ 4.84万 - 项目类别:
Designing novel therapeutics for Alzheimer’s disease using structural studies of tau
利用 tau 蛋白结构研究设计治疗阿尔茨海默病的新疗法
- 批准号:
10678341 - 财政年份:2023
- 资助金额:
$ 4.84万 - 项目类别:
A role for cardiomyocyte pannexin 1 in non-ischemic heart failure
心肌细胞pannexin 1在非缺血性心力衰竭中的作用
- 批准号:
10680109 - 财政年份:2023
- 资助金额:
$ 4.84万 - 项目类别: